Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) EBIT (2024 - 2025)

Historic EBIT for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to -$17.7 million.

  • Connect Biopharma Holdings' EBIT fell 2766.86% to -$17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$52.2 million, marking a year-over-year change of. This contributed to the annual value of -$22.5 million for FY2024, which is 6748.73% up from last year.
  • Latest data reveals that Connect Biopharma Holdings reported EBIT of -$17.7 million as of Q3 2025, which was down 2766.86% from -$13.4 million recorded in Q2 2025.
  • In the past 5 years, Connect Biopharma Holdings' EBIT ranged from a high of $13.6 million in Q2 2024 and a low of -$17.7 million during Q3 2025